Hyperhomocysteinemia in arterial or venous thrombosis: A retrospective study of 75 patients;Hyperhomocysteinemie et thromboses arterielles ou veineuses: Etude retrospective de 75 observations

Presse Medicale

Volumn 29, Issue 6, 2000, Pages 287-293

  Jacob, N ^a   Cacoub, P ^a   Hausfater, P ^a   Tazi, Z ^a   Hamidou, S ^a   Godeau, P ^a   Foglietti, M J ^a   Piette, J C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; COBALAMIN; FOLIC ACID; HOMOCYSTEINE; VITAMIN B GROUP; CYANOCOBALAMIN;

ADULT; ARTERY THROMBOSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; VEIN THROMBOSIS; VITAMIN SUPPLEMENTATION; AGED; BLOOD; MIDDLE AGED; THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS; VITAMIN B 12;

EID: 0034685090     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bertina R. Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chem 1997 ; 43:1678-83.
2. Bertina RM, Koeleman BPC, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994 ; 369:64-7.
3. European Atherosclerosis Society Study Group. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society. Eur Heart J 1987 ; 8:77-88.
4. Mudd SH. Vascular disease and homocysteine metabolism. N Engl J Med 1985 ; 313:751-3.
5. Boers GHJ, Smals AGH, Trijbels FJM et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985 ; 313:709-15.
6. Clarke R, Daly L, Robinson K et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991 ; 324:1149-55.
7. Bienvenu T, Ankri A, Chadefaux B, Montalescot G, Kamoun P. Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters. Thromb Res 1993 ; 70:123-9.
8. Fermo I, Vignano D'Angelo S, Paroni R, Mazzola G, Calori G, D'Angelo A. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Ann Intern Med 1995 ; 123:747-53.
9. Den Heijer M, Koster T, Blom HJ et al. Hyperhomocysteinemia as a risk factor for deep vein thrombosis. N Engl J Med 1996 ; 334:759-62.
10. Kang SS, Wong PWK, Norusis M. Homocysteinemia due to folate deficiency. Metabolism 1987 ; 36:458-62.
11. Brattström L, Israelsson B, Lindegarde F, Hultberg B, Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine β-synthase deficiency. Metabolism 1988 ; 37:175-8.
12. Smolin LA, Benevenga NJ. Accumulation of homocyst(e)ine in vitamin B6 deficiency. J Nutr 1982 ; 112:1264-72.
13. Kang SS, Zhou J, Wong PWK, Kowalisyn J, Strokosch G. Intermediate hyperhomocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988 ; 43:414-21.
14. Chadefaux B, Coude M, Hamet M et al. Dosage radioisotopique de la L-homocystéine totale dans le plasma et dans l'urine : application à des dosages en série. Ann Biol Clin 1990 ; 48:33-6.
15. Cacoub P, Sbai A, Ohayon V, Ghafir D, Godeau P, Piette JC. Thrombose cave supérieure, anémie hémolytique et hyperhomocystéinémie. Presse Med 1998 ; 27:65-6.
16. Rees MM, Rodgers GM. Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb Research 1993 ; 71:337-59.
17. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl Med 1998 ; 338:1042-50.
18. Malinow MR, Kang SS, Taylor LM et al. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 1989 ; 79:1180-8.
19. Brattström L, Israelson B, Norrving B et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis 1990 ; 81:51-60.
20. Mölgaard J, Malinow MR, Lassvik C, Holm A-C, Upson B, Olsson AG. Hyperhomocyst(e)inemia : an independant risk factor for intermittent claudication. J Intern Med 1992 ; 231:273-9.
21. Bergmark C, Mansoor MA, Swedenborg J, de Faire U, Svardal AM, Ueland PM. Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50 - Effect of smoking and extent of disease. Eur J Vasc Surg 1993 ; 7:391-7.
22. Falcon CR, Cattaneo M, Panzeri D, Martinelli I, Manucci PM. High prevalence of hyperhomocyst(e)inemia in patients with juvenile thrombosis. Arterioscler Thromb 1994 ; 14:1080-3.
23. Admundsen T, Ueland PM, Waage A. Plasma homocysteine levels in patients with deep veincus thrombosis. Arterioscler Thromb Vasc Biol 1995 ; 15:1321-3.
24. Simioni P, Prandoni P, Burlina A et al. Hyperhomocysteinemia and deep-veinthrombosis a case-control study. Thromb Haemost 1996 ; 76:883-6.
25. Den Heijer M, Blom HJ, Gerrits WBJ, Rosencal FR, Haak HL, Wijermars PW. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis? Lancet 1995 ; 345:882-5.
26. Savage DG, Lindenbaum J, Stabler SP, Allen RH. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folates deficiencies. Am J Med 1994 ; 96:239-46.
27. Brower DAJ, Welten HTME, Reijngoud D-J, Van Doormal JJ, Muskiet FAJ. Plasma folic acid cutoff value, derived from its relationship with homocyst(e)ine. Clin Chem 1998 ; 44:44-7.
28. Franken DG, Boers GHJ, Blom HJ, Trijbels FJM, Kloppenborg PWC. Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler Thromb 1994 ; 14:465-70.
29. Den Heijer M, Brouwer IA, Bos GMJ et al. Vitamin supplementation reduces blood homocysteine levels. A controlled trial in patients with venous thrombosis and healthy volunteers. Arterioscl Thromb Vasc Biol 1998 ; 18:356-61.
30. Homocysteine Metabolism Second International Conference Neth J Med 1998 ; 52:S1-61.
31. Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996 ; 27:517-27.
32. Miller GJ, Bauer KA, Cooper JA, Rosenberg RD. Activation of the coagulation pathway in cigarette smokers. Thromb Haemost 1998 ; 79:549-53.
33. Miller GJ. Lipids and thrombosis: effects of lipid lowering. Curr Opin Lipidol 1995 ; 6:38-42.
34. Dahlback B. Resistance to activated protein C as a risk factor for thrombosis : molecular mechanisms, laboratory investigation, and clinical management. Semin Hematol 1997 ; 34:217-34.
35. Thomas DP, Roberts HR. Hypercoagulability in venous and arterial thrombosis. Ann Intern Med 1997 ; 126:638-44.
36. Petri M, Roubenoff R, Dallal E, Nadeau MR, Shelhub J, Rosenberg IH. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 1996 ; 348:1120-4.